Semaglutide is revealed to cause medullary thyroid cell carcinoma in rodents. Although its medical relevance to people is unidentified, the FDA advises never to administer this drug in People with a private or loved ones record of medullary thyroid carcinoma. Semaglutide also poses a risk of pancreatitis and dehydration. usted https://tirzepatide88754.ivasdesign.com/52670310/not-known-factual-statements-about-retatrutide